Production (Stage)
Proto Script Pharmaceutical Corp.
PSCR
$0.0003
$0.000.00%
OTC PK
| 09/30/2017 | 06/30/2017 | 03/31/2017 | 12/31/2016 | 09/30/2016 | |
|---|---|---|---|---|---|
| Net Income | -8.39M | -8.10M | -7.84M | -7.18M | 12.60K |
| Total Depreciation and Amortization | 8.30K | 6.90K | 5.90K | 5.10K | 17.50K |
| Total Amortization of Deferred Charges | 287.90K | 177.90K | 69.10K | -- | -- |
| Total Other Non-Cash Items | 7.09M | 7.00M | 7.03M | 6.87M | 52.00K |
| Change in Net Operating Assets | 694.90K | 604.30K | 536.80K | 356.80K | -82.40K |
| Cash from Operations | -303.10K | -317.00K | -198.90K | 44.20K | -200.00 |
| Capital Expenditure | -33.80K | -36.20K | -24.60K | -15.20K | -5.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -33.80K | -36.20K | -24.60K | -15.20K | -5.70K |
| Total Debt Issued | 331.20K | 336.80K | 334.50K | 25.10K | 87.30K |
| Total Debt Repaid | 0.00 | 0.00 | -51.30K | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -25.00K | -59.50K | -75.50K |
| Cash from Financing | 331.20K | 336.80K | 258.20K | -34.40K | 11.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.80K | -16.50K | 34.70K | -5.50K | 5.90K |